| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $217 | — |
| R&D Expense | $166K | -62.0% |
| SG&A Expense | $1.1M | +17.4% |
| Operating Income | -$1.3M | -189.3% |
| Interest Expense | $57K | +261.4% |
| Pre-tax Income | -$3.1M | -24.2% |
| Net Income | -$3.0M | -22.8% |
| EPS (Basic) | -$0.02 | -100.0% |
| EPS (Diluted) | -$0.02 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $100K | — |
| Inventory | $3K | +0.0% |
| Current Assets | $198K | +75.7% |
| Total Assets | $198K | +75.7% |
| Current Liabilities | $2.6M | +63.6% |
| Total Liabilities | $2.6M | +63.6% |
| Stockholders' Equity | -$2.4M | -62.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$660K | -1.9% |
| Financing Cash Flow | $559K | +132.8% |
| -100.0% |